{"id":1198,"date":"2016-03-17T16:54:02","date_gmt":"2016-03-17T20:54:02","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1198"},"modified":"2016-03-17T17:20:15","modified_gmt":"2016-03-17T21:20:15","slug":"secondaries-announced-3-17-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-3-17-2016\/","title":{"rendered":"Secondaries announced 3.17.2016"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n

Company: \tDuPont Fabros Techmology
\nSymbol: \tDFT
\nPrice: \t\tLast trade $38.83
\nTrade Date: \t3\/18
\nShares: \t5.5 million
\nUnderwriter(s) Goldman Sachs, KeyBanc Capital Markets, Credit Suisse
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tVolitionRX
\nSymbol: \tVNRX
\nPrice: \t\tLast trade $3.62
\nTrade Date: \t3\/18
\nShares: \tTBD
\nUnderwriter(s) \tRaymond James
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tRegency Centers
\nSymbol: \tREG
\nPrice: \t\tLast trade $77.12
\nTrade Date: \t3\/18
\nShares: \t3.1 million
\nUnderwriter(s) \tJ.P. Morgan
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tHemisphere Media Group-BLOCK
\nSymbol: \tHMTV
\nPrice: \t\tLast trade $13.64
\nTrade Date: \t3\/18
\nShares: \t1 million
\nUnderwriter(s) \tRBC Capital Markets
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tTripAdvisor-BLOCK
\nSymbol: \tTRIP
\nPrice: \t\tLast trade $65.31
\nTrade Date: \t3\/18
\nShares: \t2.7 million
\nUnderwriter(s) Morgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tNational Healthcare Corp-BLOCK
\nSymbol: \tNHC
\nPrice: \t\tLast trade $65.93
\nTrade Date: \t3\/18
\nShares: \t649,000
\nUnderwriter(s) UBS
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tFidelity National Information Services-BLOCK
\nSymbol: \tFIS
\nPrice: \t\tLast trade $63.06
\nTrade Date: \t3\/18
\nShares: \t7.6 million
\nUnderwriter(s) \tMorgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: DuPont Fabros Techmology Symbol: DFT Price: Last trade $38.83 Trade Date: 3\/18 Shares: 5.5 million Underwriter(s) Goldman Sachs, KeyBanc Capital Markets,[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[767,373,770,11,769,768,771],"class_list":["post-1198","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-dft","tag-hmtv","tag-nhc","tag-reg","tag-trip","tag-vnrx","tag-fis"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1198"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1198\/revisions"}],"predecessor-version":[{"id":1200,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1198\/revisions\/1200"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}